These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 24452095)
1. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide. Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095 [TBL] [Abstract][Full Text] [Related]
2. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice. Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057 [No Abstract] [Full Text] [Related]
3. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma. Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947 [TBL] [Abstract][Full Text] [Related]
4. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Chou FI; Chung HP; Liu HM; Chi CW; Lui WY Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330 [TBL] [Abstract][Full Text] [Related]
5. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients. Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348 [TBL] [Abstract][Full Text] [Related]
6. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412 [TBL] [Abstract][Full Text] [Related]
7. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model. Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy. Fujimura A; Yasui S; Igawa K; Ueda A; Watanabe K; Hanafusa T; Ichikawa Y; Yoshihashi S; Tsuchida K; Kamiya A; Furuya S Cells; 2020 Sep; 9(10):. PubMed ID: 32977522 [TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283 [TBL] [Abstract][Full Text] [Related]
10. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Haritz D; Gabel D; Huiskamp R Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403 [TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326 [TBL] [Abstract][Full Text] [Related]
12. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618 [TBL] [Abstract][Full Text] [Related]
13. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy. Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210 [TBL] [Abstract][Full Text] [Related]
14. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy. Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288 [TBL] [Abstract][Full Text] [Related]
15. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT). Michiue H; Kitamatsu M; Fukunaga A; Tsuboi N; Fujimura A; Matsushita H; Igawa K; Kasai T; Kondo N; Matsui H; Furuya S J Control Release; 2021 Feb; 330():788-796. PubMed ID: 33188824 [TBL] [Abstract][Full Text] [Related]
16. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors. Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447 [TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT. Barth RF; Gupta N; Kawabata S Cancer Commun (Lond); 2024 Aug; 44(8):893-909. PubMed ID: 38973634 [TBL] [Abstract][Full Text] [Related]
19. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Barth RF; Zhang Z; Liu T Cancer Commun (Lond); 2018 Jun; 38(1):36. PubMed ID: 29914575 [TBL] [Abstract][Full Text] [Related]
20. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice. Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]